FGF/FGFR system inhibition as a therapeutic strategy for high-risk and chemoresistant medulloblastoma
Salva questo lavoro e mantieni la tua ricerca organizzata
Crea un account gratuito per salvare lavori, creare avvisi e tornare a questa inserzione dalla tua dashboard.
Continuando accetti i nostri Termini & Informativa sulla privacy.
Organisation/Company Università degli studi di Brescia Research Field Medical sciences » Medicine Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 1 Dec 2026 - 14:00 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Scorra verso il basso per trovare i dettagli completi dell'offerta, inclusa l'esperienza richiesta e le mansioni associate.
Offer Description
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. MB-SHH tumors with TP53 mutation and Group 3 MB, often characterized by high aggressiveness, dissemination and treatment resistance, require novel targeted strategies. The project will investigate the role of FGF/FGFR signaling and the therapeutic potential of its blockade using clinically available FGFR inhibitors and next-generation FGF-trap molecules. Murine and human cell models, primary cells, patient-derived xenograft organoids and orthotopic in vivo models will be used. Effects on tumor growth, cell signaling and the tumor microenvironment will be characterized, together with the efficacy of combination treatments with conventional and innovative chemotherapies. Particular attention will be given to chemoresistant models to determine whether FGF/FGFR targeting can overcome resistance and prevent relapse.
The evaluation criteria are established in the call; a master's degree obtained no more than six years ago is required; knowledge of Italian and English is required. xbvzest The professional expertise considered preferable for the purposes of the intended collaboration will relate to experience in cellular biology, molecular biology, the study of the tumor microenvironment, and in vivo models in experimental oncology.
- OTHER
Eligibility of fellows: country/ies of residence:
- OTHER
Eligibility of fellows: nationality/ies:
- OTHER
Public notice for the direct approval of a research position pursuant to Article 22-ter, paragraph 4, of Law No. 240/2010, a.d. MEDS-02/A “Experimental Medicine and Pathophysiology